Pladienolide B and its derivatives target the SF3B1 subunit of the U2 snRNP splicing complex, affecting the splicing of various genes, including hTERT.
Sudemycin is another SF3B1 inhibitor can disrupt the normal splicing of hTERT, leading to a reduction in active telomerase enzyme.
Resveratrol has been reported to influence alternative splicing of various genes and could potentially affect hTERT splicing indirectly by modulating splicing factors or regulatory pathways.